Search results
Showing 4231 to 4245 of 8907 results
View a complete list of all our guidance, NICE advice and quality standards currently in development
Find out what guidance is being considered for development
Outside interests of the NICE board
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Mental health services {"@context":"http://schema.org"
Find out which guidance and quality standards are awaiting development
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios for principle social workers {"@context":"http://schema
Download (PDF) Treatment pathways We have produced treatment pathways bringing together NICE
Stakeholder registration: guidelines, quality standards and indicators
How to register as a stakeholder to help us develop guidelines, quality standards and indicators.
Biographies for all current members of the diagnostics advisory committee.
See a complete list of all our guidance and quality standards currently open for consultation
A new model for evaluating and purchasing antimicrobials in the UK
Overview of NICE and NHS England’s pioneering subscription-style purchasing model for antimicrobials: its pilot with ceftazidime-avibactam and cefiderocol in 2022, expansion in 2024, supporting health technology assessments, downloadable guidance and procurement tools.
Using our content internationally. Includes information on fees and licensing agreements for both AI and non AI requests.
Find out how and where you can reuse NICE's content. Includes use of our content in the UK, use of our content internationally, use of our content for AI purposes, our content assurance process, and our information asset register.
Evidence-based recommendations on viscoelastometric point-of-care testing devices (the ROTEM, TEG and Sonoclot systems).
Evidence-based recommendations on testing for epidermal growth factor receptor tyrosine kinase (EGFR–TK) mutations in untreated, locally advanced or metastatic non-small-cell-lung cancer.